Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System

Hautmann, A. H. and Wolff, D. and Hahn, J. and Edinger, M. and Schirmer, N. and Ammer, J. and Holler, B. and Landfried, K. and Hautmann, M. G. and Ahrens, N. and Ugocsai, P. and Andreesen, R. and Holler, E. (2013) Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System. BONE MARROW TRANSPLANTATION, 48 (3). pp. 439-445. ISSN 0268-3369, 1476-5365

Full text not available from this repository. (Request a copy)

Abstract

In this retrospective analysis, 30 patients with acute GVHD (aGVHD) and 32 patients with chronic GVHD (cGVHD) treated with extracorporeal photopheresis (ECP) performed by the COBE Spectra System were evaluated. After 3 months of ECP treatment, a CR and PR were observed in 9 (30%) and 6 (20%) patients with aGVHD and in 2 (6%) and 12 (38%) patients with cGVHD. In 16 (53%) patients with aGVHD and 9 (28%) with cGVHD ECP treatment was already stopped after 3 months. One (3%) patient with aGVHD and 7 (22%) patients with cGVHD received new additional immunosuppressive therapy started during the first 3 months of ECP treatment and were classified as 'nonresponder' with regard to ECP. Of these patients a PR was achieved in one patient with aGVHD and in three patients with cGVHD. Steroids could be tapered by >= 50 in 83% of patients with aGVHD and in 29% of patients with cGVHD after 3 months of ECP treatment. Patients with aGVHD achieving a CR or PR showed a significant improved OS after allo-SCT (P=0.019). ECP is associated with significant response rates and successful reduction of steroids in patients with GVHD. Bone Marrow Transplantation (2013) 48, 439-445; doi:10.1038/bmt.2012.156; published online 27 August 2012

Item Type: Article
Uncontrolled Keywords: VERSUS-HOST-DISEASE; PEDIATRIC-PATIENTS; PHOTOCHEMOTHERAPY; SURVIVAL; MARROW; GUIDE; TERM; extracorporeal photopheresis; GVHD; hematopoietic stem cell transplantation
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin
Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 23 Apr 2020 10:30
Last Modified: 23 Apr 2020 10:30
URI: https://pred.uni-regensburg.de/id/eprint/17017

Actions (login required)

View Item View Item